May - who began work at H&K this week - said he wants to double the size of the UK pharmaceutical team and turnover by the end of next year.
May replaces Wendy Mair, who has moved to become marketing comms practice leader, and slots in above healthcare practice leader Mike Kan.
H&K's pharma team has around 25 staff and May said: 'There's every reason why the team should double in size. We're aiming for sometime in 2004 to achieve that.'
H&K's healthcare division had fee income of just over £4m in 2001, the latest year for which figures are available (PRWeek, 31 May), and May said he wanted to double that by the end of 2004.
May, who reports to H&K's UK chief executive Marie Louise Windeler, said he was also keen to win new business by 'growing link-ups' between his division and H&K's corporate and public affairs divisions.
May left Ogilvy in October last year (PRWeek, 18 October 2002) after almost three years as European president.
Meanwhile, H&K has won a competitive pitch to handle public affairs for non-profit group Nominet UK, the registry for all domain names with a .uk suffix. H&K corporate affairs MD Andrew Pharoah leads the account, reporting to Nominet comms manager Felicity Hoad.